The Effect of Sibutramine on Energy Expenditure and Appetite During Chronic Treatment Without Dietary Restriction

Int J Obes Relat Metab Disord. 1999 Oct;23(10):1016-24. doi: 10.1038/sj.ijo.0801059.

Abstract

Objective: To assess the contribution of a thermogenic effect to weight loss induced by eight weeks treatment with sibutramine (15mg/d) vs placebo in obese subjects.

Design: Randomised, placebo controlled, double blind study.

Subjects: Thirty-two (7 male, 25 female) healthy obese body mass index (BMI) 33.9+/-0.5 kg/m2 subjects completed the trial.

Measurements: Energy expenditure (EE) was measured by indirect calorimetry during a 32 h stay in a respiration chamber before and after 8 weeks treatment. Visual analogue scales were completed for assessment of appetite sensation. No dietary restriction was given.

Results: Sibutramine caused a significant weight loss compared with placebo (-2.4 kg vs+0.3 kg, P<0.001). Despite the larger weight loss after 8 weeks, 24-h EE did not decrease more in the sibutramine than in the placebo group (-2. 6% vs -2.5%, P=ns). When the changes in 24-h EE were adjusted for changes in body weight, 24-h EE decreased significantly less in the sibutramine group than in the placebo group (0.8% vs 3.8%, P<0.02). Sibutramine significantly decreased both hunger and anticipated food consumption, and increased satiety scores.

Conclusions: The weight reducing effect of sibutramine in humans is caused by a dual mechanism: reduction of energy intake by increasing satiety and decreasing hunger and prevention of the decline in EE that follows weight loss.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Appetite Depressants / pharmacology*
  • Blood Pressure / drug effects
  • Body Composition / drug effects
  • Calorimetry, Indirect
  • Cyclobutanes / pharmacology*
  • Double-Blind Method
  • Energy Metabolism / drug effects*
  • Female
  • Heart Rate / drug effects
  • Humans
  • Hunger / drug effects
  • Male
  • Obesity / drug therapy
  • Obesity / metabolism*
  • Placebos
  • Satiation / drug effects
  • Time Factors
  • Weight Loss

Substances

  • Appetite Depressants
  • Cyclobutanes
  • Placebos
  • sibutramine